HTA11 Challenges in Establishing a National Health Technology Assessment Agency in the United States: Insight from Low- and Middle-Income Countries

Abstract

In 2022, legislators in the US responded to a long-standing problem of high drug costs for patients by giving the government the power to negotiate in its Medicare program. To engage this new negotiation power, the government’s Centers for Medicare and Medicaid Services (CMS) may need to formally avail itself of health technology assessments (HTAs). As the US considers establishing a national HTA agency to conduct HTAs through Medicare, it will face numerous challenges. This paper seeks to identify some of those challenges using insight from low- and middle-income countries (LMICs) with recently established national HTA agencies.